Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity.
Journal: Immunity
Published: September 08, 2020
The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma.
Journal: Cancers
Published: December 08, 2019
Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review.
Journal: Cancers
Published: August 27, 2019
Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment.
Journal: International journal of molecular sciences
Published: September 18, 2018
Showing 1-4 of 4
Last Updated: 09/26/2026